Administration of the approved drug milrinone via venous access to treat and to prevent vasospasm

Active, not recruiting

• Conditions: SAB-induced vasospasm; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

• Registration Number: EUCTR2009-016620-32-AT
• Lead Sponsor: Dept. of Neurological Surgery, Medical University of Vienna

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-07-24
• Last Update Posted: 21 August 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

-) male or female
-) 18 > age < 80
-) WFNS score: I-IV
-) CCT-positive bleeding (min. 20 mm)
-) signed informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 80
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20

Exclusion Criteria

-) cerebral aneurysm
-) intracerbral or interventricular bleeding in absence of SAB
-) persistent vasospasm
-) severe complication at primary care of the bleeding
-) cereral pressure > 20 mmHg
-) impaired blood coagulation

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified